Skip to main content
PMC home page
Clinical and Experimental Immunology logoLink to Clinical and Experimental Immunology
. 1978 Aug;33(2):302–308.

B-cell activation of peripheral blood lymphocytes from patients with chronic lymphatic leukaemia.

K H Robèrt, E Möller, G Gahrton, H Eriksson, B Nilsson
PMCID: PMC1537573  PMID: 309812

Abstract

The mitogenic response of blood lymphocytes from twelve patients with B-cell CLL and seven healthy controls was investigated. All patients were untreated and had a typical B-cell dominance in their peripheral blood. The patients demonstrated a scattered response pattern with a higher variance than in the control group. We demonstrated examples of stimulation of DNA-synthesis by polyclonal B-cell activators (PBA) as well as inhibition. The variable pattern between the patients might result from a malignant transformation of cells originating from different lymphocyte subpopulations in different patients. Thus PBA studies of lymphocytes from CLL patients might be a valuable tool in characterizing further this clinically variable disease at the cellular level.

Full text

PDF
302

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Brittinger G., Augener W., Bremer K., Cohnen G., Dabag S., Fischer K., König E., Meusers P. Der Lymphozyt bei der chronischen lymphatischen Leukämie. Blut. 1975 May;30(5):293–308. doi: 10.1007/BF01633649. [DOI] [PubMed] [Google Scholar]
  2. Gronowicz E., Coutinho A. Functional analysis of B cell heterogeneity. Transplant Rev. 1975;24:3–40. doi: 10.1111/j.1600-065x.1975.tb00164.x. [DOI] [PubMed] [Google Scholar]
  3. Hellstrom U., Mellstedt H., Perlmann P., Holm G., PETTERSSON D. Receptors for Helix pomatia A haemagglutinin on leukaemic lymphocytes from patients with chronic lymphocytic leukaemia (CLL). Clin Exp Immunol. 1976 Nov;26(2):196–203. [PMC free article] [PubMed] [Google Scholar]
  4. Hunyadi J., Dobozy A., Husz S., Kenderessy A. S., Krizsa F. Untersuchung der Reaktivität der T-Lymphozyten bei der chronischen lymphoiden Leukamie. Z Hautkr. 1976 May 1;51(09):367–370. [PubMed] [Google Scholar]
  5. Jondal M., Holm G., Wigzell H. Surface markers on human T and B lymphocytes. I. A large population of lymphocytes forming nonimmune rosettes with sheep red blood cells. J Exp Med. 1972 Aug 1;136(2):207–215. doi: 10.1084/jem.136.2.207. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Mellstedt H., Pettersson D. Lymphocyte subpopulations in chronic lymphocytic leukemia. Characterization by cell surface markers, cytotoxic activity, and mitogenic stimulation. Scand J Immunol. 1974;3(3):303–310. doi: 10.1111/j.1365-3083.1974.tb01261.x. [DOI] [PubMed] [Google Scholar]
  7. Ostberg L., Lindblom J. B., Peterson P. A. Beta2-microglobulin on the cell surface. Specificity of inhibition of the mixed leukocyte reaction and mitogenic properties of antibodies against the two HLA antigen polypeptide chains. Eur J Immunol. 1976 Feb;6(2):108–113. doi: 10.1002/eji.1830060207. [DOI] [PubMed] [Google Scholar]
  8. Persson U. C., Hammarström L. L., Smith C. I. Macrophages are required for the dextran-sulfate induced activation of B lymphocytes. J Immunol. 1977 Sep;119(3):1138–1144. [PubMed] [Google Scholar]
  9. Ralph P., Nakoinz I., Raschke W. C. Lymphosarcoma cell growth is selectively inhibited by B lymphocyte mitogens: LPS, dextran sulfate and PPD. Biochem Biophys Res Commun. 1974 Dec 23;61(4):1268–1275. doi: 10.1016/s0006-291x(74)80421-3. [DOI] [PubMed] [Google Scholar]
  10. Ringdén O. Activation of human lymphocyte subpopulations by rabbit anti-human beta2-microglobulin and by lipopolysaccharide. Scand J Immunol. 1976;5(8):891–900. doi: 10.1111/j.1365-3083.1976.tb03039.x. [DOI] [PubMed] [Google Scholar]
  11. Schultz E. F., Davis S., Rubin A. D. Further characterization of the circulating cell in chronic lymphocytic leukemia. Blood. 1976 Aug;48(2):223–234. [PubMed] [Google Scholar]
  12. Traczyk Z., Cieśluk S., Litwin J., Arczyńska E. Evaluation of immunologic reactivity of lymphocytes from patients with chronic lymphocytic leukemia in various clinical conditions. Arch Immunol Ther Exp (Warsz) 1975;23(5):589–596. [PubMed] [Google Scholar]
  13. Utsinger P. D. Impaired T-cell transformation in chronic lymphocytic leukemia (CLL): Demonstration of a blastogenesis inhibitory factor. Blood. 1975 Dec;46(6):883–890. [PubMed] [Google Scholar]

Articles from Clinical and Experimental Immunology are provided here courtesy of British Society for Immunology

RESOURCES